AI Verdict
GMED has stronger fundamentals based on our AI analysis.
GMED vs GMBLZ Fundamental Comparison
| Metric | GMED | GMBLZ |
|---|---|---|
| Revenue | $2.9B | $7.0M |
| Net Income | $537.9M | $-24.7M |
| Net Margin | 18.3% | -352.9% |
| ROE | 11.8% | N/A |
| ROA | 10.1% | -531.6% |
| Current Ratio | 4.26x | 0.20x |
| Debt/Equity | 0.00x | N/A |
| EPS | $3.92 | $-95.07 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GMED vs GMBLZ: Frequently Asked Questions
Is GMED or GMBLZ a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GMED has stronger fundamentals. GMED is rated BUY (78% confidence) while GMBLZ is rated STRONG SELL (94% confidence). This is not investment advice.
How does GMED compare to GMBLZ fundamentally?
GLOBUS MEDICAL INC has ROE of 11.8% vs ESPORTS ENTERTAINMENT GROUP, INC.'s N/A. Net margins are 18.3% vs -352.9% respectively.
Which stock pays higher dividends, GMED or GMBLZ?
GMED has a dividend yield of N/A or no dividend while GMBLZ has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GMED or GMBLZ for long term?
For long-term investing, consider that GMED has BUY rating with 78% confidence, while GMBLZ has STRONG SELL rating with 94% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GMED vs GMBLZ?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GMED vs GMBLZ, the AI consensus favors GMED based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.